Skip to Main Content

Flat is the new killing it.

Amgen’s (AMGN) first-quarter earnings beat Wall Street’s expectations on Tuesday night, and so the market was sated. But is anyone worried about the company’s growth?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!